CRL

$300.30 -1.02% $-3.08
Oct 7, 2026 04:00 AM

Charles River Laboratories provides essential products and services to the pharmaceutical and biotechnology industries, focusing on drug development and discovery.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Oct 7, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Reveal Your CRL Trading Now

Revolutionize your investment in CRL with OHLCX Platform’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Start optimizing your trades today with OHLCX Platform now and achieve better trading outcomes!

Discover More Now

Frequently Asked Questions

Consider risks such as changes in healthcare regulations, market competition, and dependency on the pharmaceutical sector.

You can track CRL stock performance through brokerage platforms, financial news websites, and stock market apps.

Charles River Laboratories does not currently pay dividends, focusing on reinvesting in growth opportunities.

Analysts provide insights based on market trends and financial reports; check recent analyst reports for evaluations.

Recent developments include mergers and acquisitions, changes in regulatory environments, and quarterly earnings reports.

CRL stock performance can vary; consult financial news outlets for the latest updates and market analysis.

Competitors include Covance, WuXi AppTec, and Charles River’s other service providers in the life sciences sector.

Charles River regularly evaluates opportunities for expansion and innovation; stay updated through their press releases and earnings calls.

To determine if CRL is a good long-term investment, consider industry trends, financial health, and growth potential.

Factors include industry demand for preclinical and clinical services, regulatory changes, and overall market conditions.

Improve Your CRL Trading Now

Empower your trading with ohlcx.com. Our comprehensive platform delivers precise analysis and strategic insights for CRL, designed to improve your trading outcomes. Transform your trading strategy now and unlock new opportunities with our advanced system!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.